<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="publisher-id">PAMJ</journal-id>
      <journal-title-group>
        <journal-title>The Pan African Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1937-8688</issn>
      <publisher>
        <publisher-name>The African Field Epidemiology Network</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23396644</article-id>
      <article-id pub-id-type="pmc">3567412</article-id>
      <article-id pub-id-type="publisher-id">PAMJ-13-77</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Null phenotype non-Hodgkin Lymphoma presenting as a large chest wall mass: case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sekkate</surname>
            <given-names>Sakina</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="corresp" rid="cor1">&amp;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kairouani</surname>
            <given-names>Mouna</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mellas</surname>
            <given-names>Nawfal</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>El Kabbaj</surname>
            <given-names>Hanane</given-names>
          </name>
          <xref ref-type="aff" rid="AF0002">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>M'rabti</surname>
            <given-names>Hind</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Errihani</surname>
            <given-names>Hassan</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
      </contrib-group>
      <aff id="AF0001"><label>1</label>Department of Clinical Oncology, Hassan II Hospital, Fes, Morocco</aff>
      <aff id="AF0002"><label>2</label>Department of Radiotherapy, National Institute of Oncology, 10100, Rabat, Morocco</aff>
      <author-notes>
        <corresp id="cor1"><label>&amp;</label>Corresponding author: Sakina Sekkate, Department of Clinical Oncology, National Institute of Oncology, 10100, Rabat, Morocco</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <volume>13</volume>
      <elocation-id>77</elocation-id>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>8</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Sakina Sekkate et al.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Tumors of chest wall represent a variant entity. Most of them arise from metastasis of malignant tumors or from local invasion by contiguity. However, non-Hodgkin's lymphomas of the chest wall are extremely rare; only a few cases have been reported in the literature. We report a case about a Moroccan woman, with non-Hodgkin null phenotype lymphoma of the chest, treated successfully with CHOP (cyclophosphamide, Doxorubicin, Vincristin and prednisone) followed by local radiotherapy.</p>
      </abstract>
      <kwd-group>
        <kwd>Lymphoma</kwd>
        <kwd>null phenotype</kwd>
        <kwd>chest tumor</kwd>
        <kwd>diagnosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="S0001">
      <title>Introduction</title>
      <p>Chest wall tumors arise from a large variety of malignant and benign etiologies, and present a diagnostic challenge for the clinician. The classification of chest wall tumors includes primary tumors, adjacent tumors with local invasion, metastatic lesions, and non neoplastic disease [<xref ref-type="bibr" rid="CIT0001">1</xref>, <xref ref-type="bibr" rid="CIT0002">2</xref>]. Non-Hodgkin lymphoma presenting as a solitary chest wall mass is not frequently seen [<xref ref-type="bibr" rid="CIT0001">1</xref>].</p>
    </sec>
    <sec id="S0002">
      <title>Patient and observation</title>
      <p>A 60-year-old woman with no history of tuberculosis, pyothorax or artificial pneumothorax therapy, presented 4 months before her admission an asthenia, fever, chills, and night sweats. Physical examination revealed a mass of 10 cm localised in lateral chest wall (<xref ref-type="fig" rid="F0001">Figure 1</xref>). ignificant laboratory findings were as follows: haemoglobin: 9,3g/dL, erythrocyte sedimentation rate: 60 mm/h, LDH rate: 620 UI/ml. Computed tomographic scan confirmed the localisation in chest wall with invasion of the ribs (<xref ref-type="fig" rid="F0002">Figure 2</xref>).</p>
      <fig id="F0001" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>The chest wall tumor measuring 10 cm in diameter</p>
        </caption>
        <graphic xlink:href="PAMJ-13-77-g001"/>
      </fig>
      <fig id="F0002" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Computed tomography scan of the chest:Soft tissue mass lesion in posterior chest wall with thorax extension accompanied by pleural thickening</p>
        </caption>
        <graphic xlink:href="PAMJ-13-77-g002"/>
      </fig>
      <p>A biopsy of the chest tumor was performed and revealed a non-Hodgkin lymphoma with null phenotype. Immunohistochemical staining of the specimen was positive for leukocyte common antigen, CD20, and Ki67 and negative for CD3, vimentin, desmin, chromogranin, neuron specific enolase, CD99, and actin.</p>
      <p>The patient received four cycles of chemotherapy CHOP 21 (Cyclophosphamide 750 mg/m2 Intraveinously (IV) at day1, doxorubicin 50 mg/m2 IV at day1, vincristine 1, 4 mg/m2 with a maximum total dose of 2 mg IV at day1 and prednisone 40 mg/m2/day per os from day 1 to 5) followed by local radiotherapy, total dose was 40 Gy delivered as 2Gy daily fractions, 5 day per week. She had a complete response maintained for more than 7 months.</p>
    </sec>
    <sec sec-type="discussion" id="S0003">
      <title>Discussion</title>
      <p>The majority of chest wall lesions arise from metastasis or invasion from adjacent malignancies [<xref ref-type="bibr" rid="CIT0001">1</xref>]. Among primary chest wall tumors, chest wall lymphoma is extremely rare, accounting for less than 2% of chest wall soft tissue tumors [<xref ref-type="bibr" rid="CIT0002">2</xref>, <xref ref-type="bibr" rid="CIT0003">3</xref>]. Few cases of primary malignant lymphoma, arising from the sternum, the pleura or the rib have been reported. Primary bone lymphoma can result from any part of the skeleton. The most common tumor sites are the long bones (50% extremities), followed by the axial skeleton (44%) [<xref ref-type="bibr" rid="CIT0002">2</xref>].</p>
      <p>Our patient had a primary non-Hodgkin lymphoma in the ribs. Primary lymphoma of the bone (PLB), which was first reported by Oberling, [<xref ref-type="bibr" rid="CIT0004">4</xref>] accounts for approximately 4.7% of extranodal lymphomas. The majority of cases occur in long bones, spine, or pelvic, and rib involvement is rare (2% to 15% of cases of PLB). According to a review by Ostrowski and associates, the mean age at presentation was 46 years with male predominance. The most frequent symptoms are pain, swelling, fever, night sweats, and body weight loss, as in other lymphoma conditions. [<xref ref-type="bibr" rid="CIT0005">5</xref>] Because imaging study of chest wall tumor suggesting PLB is not diagnostic, a histologic specimen is needed [<xref ref-type="bibr" rid="CIT0006">6</xref>].</p>
      <p>The treatment in general is conservative, based on the stage of disease. PBL therapy has envolved from radiotherapy as a standalone strategy (since the 1960s) to combined modality therapy (chemotherapy and radiotherapy) [<xref ref-type="bibr" rid="CIT0004">4</xref>]. There have also been a few reports of patients treated with chemotherapy alone [<xref ref-type="bibr" rid="CIT0002">2</xref>, <xref ref-type="bibr" rid="CIT0003">3</xref>]. There is no definitive therapeutic strategy. Local radiation is recommended, and additional systemic chemotherapy seems to be effective [<xref ref-type="bibr" rid="CIT0006">6</xref>]. Recently, Mavrogenis and al [<xref ref-type="bibr" rid="CIT0007">7</xref>], reported the role of surgery for heamatologic neoplasms of bone about 205 patients treated from 1985 to 2009, the survival to death was improved after wild resection for lymphoma and plasmacytoma. But no statistical difference was noted in survival to local recurrence between wide and intralesional surgery.</p>
    </sec>
    <sec sec-type="conclusion" id="S0004">
      <title>Conclusion</title>
      <p>Primary chest lymphoma is rare; therefore, the therapeutic management is unclear. Data on the treatment and evolution of this disease should be reported.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>We would like to thank the department of radiology.</p>
    </ack>
    <sec id="S0005">
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec id="S0006">
      <title>Authors&#x2019; contributions</title>
      <p>All the authors have contributed to this work. All authors read and approved the final manuscript.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="CIT0001">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsu</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>AF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Non-Hodgkin's Lymphoma Presenting as a large chest wall lymphoma</article-title>
          <source>Ann Thorac Surg.</source>
          <year>2006</year>
          <month>4</month>
          <volume>81</volume>
          <issue>4</issue>
          <fpage>1214</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">16564245</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0002">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tateishi</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Gladish</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Kusumoto</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chest wall tumors: radiologic findings and pathologic correlation: part 2</article-title>
          <source>Malignant tumors. Radiographics.</source>
          <year>2003</year>
          <season>Nov-Dec</season>
          <volume>23</volume>
          <issue>6</issue>
          <fpage>1491</fpage>
          <lpage>508</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0003">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>King</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Pairolero</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Trastek</surname>
              <given-names>VF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary chest wall tumors: factors affecting survival</article-title>
          <source>Ann Thorac Surg.</source>
          <year>1986</year>
          <month>6</month>
          <volume>41</volume>
          <issue>6</issue>
          <fpage>597</fpage>
          <lpage>601</lpage>
          <pub-id pub-id-type="pmid">3013106</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0004">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oberling</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Les r&#xE9;ticulosarcomes et les r&#xE9;ticuloendoth&#xE9;li-osarcomes de la moelle osseuse (sarcomes d'Ewing)</article-title>
          <source>Bull Assoc Fr Cancer.</source>
          <year>1928</year>
          <volume>17</volume>
          <fpage>259</fpage>
          <lpage>63</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0005">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Durr</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Hiller</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Maier</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baur</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jansson</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Malignant lymphoma of bone</article-title>
          <source>Arch Orthop Trauma Surg.</source>
          <year>2002</year>
          <volume>122</volume>
          <fpage>10</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">11995873</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0006">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tabatabai</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hashemi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ahmadinejad</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary chest wall lymphoma with no history of tuberculous pyothorax: Diagnosis and treatment</article-title>
          <source>J Thorac Cardiovasc Surg.</source>
          <year>2008</year>
          <month>12</month>
          <volume>136</volume>
          <issue>6</issue>
          <fpage>1472</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">19114192</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0007">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mavrogenis</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Angelini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pala</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The role of surgery for heamatologic neoplasms of bone</article-title>
          <source>Acta Orthop Belg.</source>
          <year>2012</year>
          <month>6</month>
          <volume>78</volume>
          <issue>3</issue>
          <fpage>382</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">22822581</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
